Are COVID-19 Vaccines Safe and Effective?
Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
EurekAlert!1d
Topical steroid withdrawal diagnostic criteria defined by NIH researchers
Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...
LAist on MSN1d
NIH cuts funding for vaccine-hesitancy research. mRNA research may be next
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Capitol Q&A: Auchincloss on Trump, RFK Jr. and Vaccines
Democratic Rep. Jake Auchincloss says Trump is ‘undermining the rule of law’ and weighs in on Robert F. Kennedy Jr. and the ...
Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial
NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions. Colorized transmission electron micrograph of immature mpox virus particles (blue with red viral envelope) ...